» Articles » PMID: 30874421

Radiofrequency-Sensitive Longitudinal Relaxation Tuning Strategy Enabling the Visualization of Radiofrequency Ablation Intensified by Magnetic Composite

Overview
Date 2019 Mar 16
PMID 30874421
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

As a minimally invasive heat source, radiofrequency (RF) ablation still encounters potential damages to the surrounding normal tissues because of heat diffusion, high power, and long time. With a comprehensive understanding of the current state of the art on RF ablation, a magnetic composite using porous hollow iron oxide nanoparticles (HIONs) as carriers to load dl-menthol (DLM) has been engineered. This composite involves two protocols for enhancing RF ablation, that is, HION-mediated magnetothermal conversion in RF field and RF solidoid vaporation (RSV)-augmented inertial cavitation, respectively. A combined effect based on two protocols is found to improve energy transformation, and further, along with hydrophobic DLM-impeded heat diffusion, improve the energy utilization efficiency and significantly facilitate ex vivo and in vivo RF ablation. More significantly, in vitro and in vivo RSV processes and RSV-augmented inertial cavitation for RF ablation can be monitored by T-weighted magnetic resonance imaging (MRI) via an RF-sensitive longitudinal relaxation tuning strategy because the RSV process can deplete DLM and make HION carriers permeable to water molecules, consequently improving the longitudinal relaxation rate of HIONs and enhancing T-weighted MRI. Therefore, this RF-sensitive magnetic composite holds a great potential in lowering the power and time of RF ablation and improving its therapeutic safety.

Citing Articles

Magnetothermal-activated gene editing strategy for enhanced tumor cell apoptosis.

Li M, Li S, Guo Y, Hu P, Shi J J Nanobiotechnology. 2024; 22(1):450.

PMID: 39080645 PMC: 11287911. DOI: 10.1186/s12951-024-02734-8.


Tissue Ablation: Applications and Perspectives.

Keum H, Cevik E, Kim J, Demirlenk Y, Atar D, Saini G Adv Mater. 2024; 36(32):e2310856.

PMID: 38771628 PMC: 11309902. DOI: 10.1002/adma.202310856.


The Emerging Landscape for Combating Resistance Associated with Energy-Based Therapies via Nanomedicine.

Hu Q, Zuo H, Hsu J, Zeng C, Tian Z, Sun Z Adv Mater. 2023; 36(5):e2308286.

PMID: 37971203 PMC: 10872442. DOI: 10.1002/adma.202308286.


Nanodrugs with intrinsic radioprotective exertion: Turning the double-edged sword into a single-edged knife.

Guo J, Zhao Z, Shang Z, Tang Z, Zhu H, Zhang K Exploration (Beijing). 2023; 3(2):20220119.

PMID: 37324033 PMC: 10190950. DOI: 10.1002/EXP.20220119.


Sequential Ubiquitination and Phosphorylation Epigenetics Reshaping by MG132-Loaded Fe-MOF Disarms Treatment Resistance to Repulse Metastatic Colorectal Cancer.

Bu Z, Yang J, Zhang Y, Luo T, Fang C, Liang X Adv Sci (Weinh). 2023; 10(23):e2301638.

PMID: 37303273 PMC: 10427397. DOI: 10.1002/advs.202301638.